Vivek Subbiah: A morning walk to support melanoma research

Vivek Subbiah posted on X by himself adding:

“Amazing day for a morning walk to support melanoma research – melanoma 5k walk ! Slip! Slop! Slap! and Wrap! h/t American Cancer Society.

If you are going to be in the sun, this catchphrase can help you remember some of the key steps you can take to protect yourself from UV rays:

•Slip on a shirt.
•Slop on sunscreen.
•Slap on a hat.
•Wrap on sunglasses to protect the eyes and sensitive skin around them.

Read about more.”

Quoting himself below:

“Fantastic day and amazing weather in Nashville, TN for a morning walk with the melanoma clinical research Dream team Sarah Cannon Docs, SCRI Oncology Partners supporting the AIM at Melanoma Foundation for melanoma awareness, education and research.”

Source: Vivek Subbiah/X

Vivek Subbiah is the Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA). He is the former Executive Director of Oncology Research and former Associate Professor in the Department of Investigational Cancer Therapeutics at the MD Anderson Cancer He focuses on translational cancer research and the design and implementation of early-phase biomarker-driven clinical trials. His work specifically targets antibody-drug conjugates, radiopharmaceuticals, immunoconjugates, and basket trials.